(Q43265529)

17 November 2017

Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks (English)

1 reference

17 November 2017

1 reference

1 reference

J L Brandes

1

1 reference

17 November 2017

A c Poole

2

1 reference

17 November 2017

M Kallela

3

1 reference

17 November 2017

C P Schreiber

4

1 reference

17 November 2017

E A MacGregor

5

1 reference

17 November 2017

S D Silberstein

6

1 reference

17 November 2017

J Tobin

7

1 reference

17 November 2017

R Shaw

8

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

29

1 reference

17 November 2017

11

1 reference

17 November 2017

1133-1148

1 reference

Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment

17 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Prevalence of migraine on each day of the natural menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Efficacy of oral naratriptan in the treatment of menstrually related migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Serotonin and migraine: biology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

The influence of estrogen on migraine: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Sample size calculations for ordered categorical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

Patient-centered outcomes for frequent headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01840.X

10.1111/J.1468-2982.2009.01840.X

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference